4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000106
Chairperson & CEO sold 9,500 shares at an average $531.74 ($5,051,519)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-07-24 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $135.42 | $1,286,490 | 333,943 | I |
| 2026-07-24 | Sale : show line 2 in the form 10b5-1 | −820 | $528.72 | $433,549 | 333,123 | I |
| 2026-07-24 | Sale : show line 3 in the form 10b5-1 | −2,285 | $530.45 | $1,212,080 | 330,838 | I |
| 2026-07-24 | Sale : show line 4 in the form 10b5-1 | −1,115 | $531.10 | $592,179 | 329,723 | I |
| 2026-07-24 | Sale : show line 5 in the form 10b5-1 | −2,719 | $532.27 | $1,447,229 | 327,004 | I |
| 2026-07-24 | Sale : show line 6 in the form 10b5-1 | −1,818 | $533.20 | $969,356 | 325,186 | I |
| 2026-07-24 | Sale : show line 7 in the form 10b5-1 | −630 | $534.39 | $336,668 | 324,556 | I |
| 2026-07-24 | Sale : show line 8 in the form 10b5-1 | −113 | $535.03 | $60,458 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $531.74 · $5,051,519 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-07-24 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option | −9,500 | 274,910 | I |
Loading xslF345X06/primarydocument.xml…